ArticleGeburtshilfe und Frauenheilkunde2018

Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians.

Paul Gass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.